Enrolling by Invitation
Carrelizumab Combined With Concurrent Radiotherapy and Chemotherapy for Unresectable Esophageal Squamous Cell Carcinoma
NCT06048926
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +12 more
- Locations
-
- The First Affiliated Hospital of Nanjing Medical University Nanjing, China